Investing.com - AbbVie (NYSE:ABBV) reported on Friday first quarter earnings that beat analysts' forecasts and revenue that fell short of expectations.
AbbVie announced earnings per share of $3.16 on revenue of $13.54B. Analysts polled by Investing.com anticipated EPS of $3.14 on revenue of $13.67B.
AbbVie shares are down 14.31% from the beginning of the year and are trading at $157.86 , down-from-52-week-high.They are under-performing the S&P 500 which is down 10.04% from the start of the year.
AbbVie shares gained 0.99% in pre-market trade after the report.
AbbVie follows other major Healthcare sector earnings this month
AbbVie's report follows an earnings beat by UnitedHealth on Thursday, April 14, 2022, who reported EPS of $5.49 on revenue of $80.15B, compared to forecasts EPS of $5.36 on revenue of $78.73B.
J&J had beat expectations on Tuesday, April 19, 2022 with first quarter EPS of $2.67 on revenue of $23.43B, compared to forecast for EPS of $2.59 on revenue of $23.62B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar